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COMMENTARY

How Can We Better Evaluate Complex Global Health
Initiatives? Reflections From the January 2014 Institute
of Medicine Workshop
Sangeeta Mookherji,a Kate Meckb

An IOM workshop on evaluation design drew on recent evaluations of 4 complex initiatives (PEPFAR;
the Global Fund to Fight AIDS, TB and Malaria; the President’s Malaria Initiative; and the Affordable
Medicines Facility-malaria). Key components for good evaluations: (1) a robust theory of change
to understand how and why programs should work; (2) use of multiple analytic methods; and
(3) triangulation of evidence to validate and deepen understanding of results as well as synthesis
of findings to identify lessons for scale-up or broader application.

T

he context for global health interventions and their
evaluations has become more complex in the 21st
century. Donor assistance for global health has
increased dramatically in the last 15 years, and most
of these resources are channeled through complex
global health initiatives that target various health
outcomes through a multitude of interventions, implemented by diverse partners in multiple countries and
regions of the world. Rigorous evaluations are needed
to assess the achievements of these initiatives and to
justify and increase investments in them. Large-scale
evaluations of complex global health initiatives are
relatively new, and knowledge of how to improve such
evaluations is needed.
Our recent experiences have repeatedly exposed the
challenges in evaluating global health initiatives that
involve any degree of complexity. Health initiatives are
often implemented at national scale, and reasonable
comparison groups cannot be identified. Even though
many initiatives monitor progress toward outputs and
outcomes using performance- or results-based strategies, these strategies rarely provide insight as to
whether or how different implementing partners were
able to achieve success; what problems were or were not
addressed successfully; and how situational variability
affected successes and challenges. Often, we simply don’t
gain the learning needed from evaluations about how a
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complex intervention worked or did not, and how
implementation context affected intervention success.
We need to do better with designing and
conducting more complex evaluations of complex
global health initiatives and to do this in creative yet
robust ways that allow us to understand both the
complexity and the specificity of implementation
context. This will require support and input from
program implementers, evaluators, and commissioners of evaluations. In this article, we report on
key messages from a workshop on ‘‘Evaluation
Design for Complex Global Health Initiatives,’’
convened by the Institute of Medicine (IOM) in
January 2014, during which workshop participants
discussed just how this might be done.

OVERVIEW OF IOM WORKSHOP
What information do we need to scale-up and sustain a
success story? What can failure to achieve expected health
effects teach us about how implementation conditions
and the political landscape contributed to the observed
results? What can evaluators do better when evaluating
complexity in global health initiatives?
The IOM asked workshop participants to address
these important questions. The goal of the workshop
was to extend evaluation methodology by capturing
lessons learned from recent large-scale, complex,
multinational global health initiatives. The workshop
derived lessons learned from the execution of evaluations and discussed how to apply lessons to future
evaluations.1
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Four recent evaluations served as core examples for the workshop:


The US President’s Emergency Plan for AIDS
Relief (PEPFAR)2



The Global Fund to Fight AIDS, Tuberculosis
and Malaria (Global Fund)3



The US President’s Malaria Initiative (PMI)4



The Affordable Medicines Facility-malaria
(AMFm)5

For the core examples, ‘‘large-scale’’ was
defined as having total cumulative budgets, over
multiple years, in at least the hundreds of millions
of US dollars. ‘‘Multinational’’ meant implementation on a global scale, including multiple countries
and regions or subregions of the world. ‘‘Complex’’
referred to several dimensions of the initiative:
multiple activity components; varied settings for
implementation of different sets of activities;
systems-strengthening efforts; capacity building;
efforts to influence policy changes; use of health
diplomacy to achieve the aims of the initiative; and
implementation at multiple levels through a large
number of diverse, multisectoral partners at the
country level.1
The IOM invited representatives from each of
the 4 core evaluations to elucidate the decision
making process and the options that were
available to develop and implement a credible
and rigorous evaluation that was also feasible,
affordable, and maximally matched to the
priority evaluation questions, aims, and audiences. In addition, representatives from other
evaluations that met some, but not necessarily
all, of the criteria above (Box), were asked to
serve as panelists and to present their experiences and perspectives on the methodological
challenges they addressed. Evaluation experts
from other relevant disciplines, including education, climate and environment, and other nonhealth areas, along with commissioners of
evaluations, held honest discussions over the
course of 2 days regarding the challenges of and
lessons learned from conducting evaluations of
complex, large-scale, multinational global health
initiatives.
The IOM workshop proceedings were published
in June 2014.1 We used the published proceedings
as a data source and applied 34 codes using NVivo
to distill the large amount of information in
the proceedings text into key messages. (See the
supplementary materials for details about the
coding methodology and summary.) Although
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BOX. Global Health Initiatives and
Evaluations Represented at IOM
Workshop, January 2014
Four recent evaluations of large-scale,
multinational, complex global health initiatives served as core examples for the
workshop:
 Global Fund to Fight AIDS, Tuberculosis

and Malaria (Global Fund)

Evaluations of
complex global
health initiatives
need to provide
information on
both the
complexity and
specificity of
implementation
context.

 US President’s Malaria Initiative (PMI)
 Affordable Medicines Facility–malaria

(AMFm)
 US President’s Emergency Plan for AIDS

Relief (PEPFAR)
Other evaluation experiences were presented that had addressed issues of complexity and scale:
 Global Environment Fund (GEF)
 Gavi (formerly, the Global Alliance for

Vaccines and Immunisation)
 Integrated Management of Childhood

Illness (IMCI)
 Accelerated Child Survival Development

(ACSD) Program
 Africa

Routine Immunization System
Essentials (ARISE)

 Saving Mothers, Giving Life
 Avahan in India
 Expanded Quality Management Using

Information Power (EQUIP)
the proceedings are comprehensive, the publication
organizes the workshop information chronologically. The free-form discussion sessions and information sharing, as well as the linkages among
dedicated panel sessions, meant that, for example,
relevant lessons on addressing context could be
found throughout the 115-page text. We used the
coding exercise to further organize the information
in the proceedings document to make the important lessons and messages more accessible for
practitioners of global health evaluations. Both
authors were workshop participants, and one a
panelist, so we also used our own participant
observations to triangulate and synthesize the
following lessons and recommendations from the
workshop.
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KEY MESSAGES ABOUT EVALUATING
COMPLEX GLOBAL HEALTH INITIATIVES
FROM THE IOM WORKSHOP
Three areas of focus to improve future evaluation
of complex global health initiatives were identified at the IOM workshop: (1) the importance of
theory of change for grounding complex evaluations; (2) the need to use multiple methods to
address complexity; and (3) the need to focus
more on triangulation and synthesis of findings.

Theory of Change Grounds Complex
Evaluations
A theory of
change depicts the
series of expected
causal steps
leading from
program activities
to outcomes and
impacts.

Workshop participants confirmed the critical role
of theory of change (ToC) that depicts the series
of expected causal steps between activities and
impacts for optimizing complex evaluations.
Participants used various terms—logic models,
results chain, causal chain pathway, program
impact pathway, program theory, and program
impact theory—but whatever the name, workshop participants confirmed that a ToC is most
Theories of change useful when it identifies the links in program
planning, implementation, and delivery and
help evaluators
address the critical especially the central assumptions, implementation conditions, and contextual factors that are
role of context.
likely to influence a complex initiative. The panel
discussions confirmed the crucial need for developing a ToC for all program purposes: design,
implementation, and continuous performance
improvement, as well as for evaluation.
A critical early step in the PEPFAR evaluation
was developing a ToC (program impact pathway)
that incorporated the various inputs into the
PEPFAR initiative, including the considerable
financial and technical assistance resources and
the strategies, guidance, and planning activities
that support implementation of the initiative.2
This ToC was then simplified to cover the
diversity of programs and used to communicate
to a variety of audiences about the evaluation.
The ToC helped the evaluation committee explore
the feasibility of the various designs and methods
that might be used in the evaluation, and then it
was used during analysis to help the committee
understand the impacts of PEPFAR in terms of
proximal, intermediate, and distal effects.1
The AMFm evaluation team developed a ToC
to depict the causal pathways through which
AMFm interventions were intended to work. This
ToC was used to target the collection of quantitative and qualitative data that would be used to
Global Health: Science and Practice 2015 | Volume 3 | Number 2
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prepare case studies for each country, thereby
providing a standard framework for evaluation
across countries for data collection and later for
analysis. The evaluation team collected qualitative data through interviews with key stakeholders from the public and private sector and a
review of key documents to understand the
AMFm implementation processes and contextual
factors identified by the ToC within each country.
The evaluation team used quantitative data from
the outlet surveys on process-related outcomes,
such as coverage of training and exposure to
communications messages. These were analyzed
separately for each country case study and then
synthesized into findings across countries.
ToCs helped evaluators address the critical
role of context. The Global Fund explained that it
takes an open approach to causation that
considers alternative hypotheses involving context, often starting with impact and outcomes
and working back along the causal chain pathway
to identify other change factors that could be
dependent on context.1 In the PEPFAR evaluation, the issue of context surfaced early during
design of the evaluation, as the committee
understood that the program impact pathway for
PEPFAR operations was embedded in the context of
many other factors in each country; the evaluation
team then examined a variety of indicators across
countries to give a contextual background to
PEPFAR’s operating environment. Contextual
issues in countries visited were explored through
the significant qualitative data collection component of the PEPFAR evaluation.1 One of the lessons
from the AMFm evaluation was the importance of
documenting the process of implementation using
a ToC model when large-scale, complex interventions are being implemented in a messy, real-world
setting.1 In fact, the AMFm evaluation found that
context probably made the most crucial difference
between countries in terms of performance.
Workshop participants continually emphasized the need to pay more attention to context
and challenged each other to ‘‘really unpack what
the notion of context means,’’ including recognizing that contextual issues arise at micro-,
meso-, and macro- levels and that they can evolve
over time. The participants called for better
differentiation between contextual ‘‘constants,’’
which cannot be influenced; contextual factors
that can be influenced; and contextual factors
that directly support the observed changes. If
evaluators parse context in this way, it may
become clear that controlling for contextual
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complexity through study design may not be
desirable in many evaluation situations, because
this could strip out the very things that are
important mechanisms for change.1 Including
contextual factors and categorizing them this way
in a comprehensive ToC is the crucial step that
allows comprehension of how and why a program
worked the way it did, and whether it would
work that way somewhere else or at larger scale.

Using Multiple Methods Helps
Address Complexity
Workshop participants affirmed that for complex
global health initiatives, evaluations need to use a
methodological approach that includes multiple
data collection and analysis methods, often through
nested study designs that combine qualitative and
quantitative approaches to data collection and
analysis, to address a variety of evaluation questions. ‘‘Multiple’’ and ‘‘mixed’’ methods described
how the 4 large-scale evaluation examples used a
number of complementary methods to arrive at
evaluation findings and conclusions. Most panelists
agreed that 2 sources of data are often not enough
to have confidence in the results from a complex
evaluation—hence, panelists mostly referred to
‘‘multiple’’ methods, and not just mixed methods.1
The critical question faced by each of the
4 core examples was how to ensure that these
multiple methods were mixed, and not mixed up
or parallel. These issues had to be addressed
during both the design and the analysis stages, to
ensure that any qualitative and quantitative data
collection conducted in parallel were linked during
analysis and that data from different sources were
collected in a way to allow triangulation later on.
The end result of the PEPFAR design phase was
a ‘‘hybrid’’ evaluation that included retrospective
and cross-sectional elements, as well as time series
and time trend data and nested in-depth
approaches on different topical areas. The approach
used multiple sources of qualitative and quantitative data to balance the limitations of each other.1
One of the primary challenges was that few data
sources were available consistently across the entire
PEPFAR program. The PEPFAR evaluation team
instead focused on using the best methods for each
type of data and matched the appropriate analytical
methods to different types of data.
The AMFm team learned the importance of
standardizing data collection and analysis methods
to assure quality. The team also recognized the
challenges of mounting a large primary data
collection exercise that is constrained on the one
Global Health: Science and Practice 2015 | Volume 3 | Number 2

www.ghspjournal.org

hand by epidemiology and logistics and on the other
hand by dependency on countries for data that may
not be forthcoming within the required timeline.
Finally, relying on secondary analysis for key outcomes was a limitation but one that could not be
overcome because of budgetary and time restrictions.
The PMI evaluation started with a qualitative
management review exercise in which the primary
sources of data were key stakeholder interviews
with PMI leadership, as well as global, regional,
and in-country stakeholders who benefit from the
initiative. While this was a relatively straightforward activity, the evaluation team soon recognized
that it needed to explore other data to understand
what the program was actually doing. This
included both quantitative data about key interventions and qualitative data about strengthening
health systems and capacity building within
national malaria control programs; for the latter,
it was useful to look at program data from other
donors supporting malaria control, such as the
Global Fund, as yet another source of data.
The Global Fund data, for example, might show
the total number of drugs and nets purchased and
delivered to a country, but to understand distribution and consumption, the PMI evaluation team
had to look to other sources. It was more difficult
to understand whether PMI was strengthening
health systems or national malaria control efforts.
The evaluation team considered the methodological trade-offs when deciding on the right mix of
qualitative and quantitative methods and use of
routine program monitoring data, and the need to
balance these trade-offs to generate results that
were useful and informative.
To implement multiple methods well and
produce useful evaluations of complex interventions, multidisciplinary teams of evaluators are
needed. Evaluators and commissioners of evaluations noted it is difficult to assemble teams
comprising individuals with the wide range of
skills required for evaluating complex programs.
Working with a multidisciplinary team of investigators to do good multidisciplinary science also
is a major challenge. The approach taken by the
PMI evaluation team was to match the team
member with the dominant relevant expertise for
each key issue with someone who had a
completely different set of expertise—someone
with a different perspective. The result was a
richer understanding of the analysis. Investing in
multidisciplinary collaboration and capacity
building for complex evaluation, especially
among local partners, often required more time

Recent
evaluations of
4 complex global
health initiatives
used multiple,
complementary
research methods.

Multidisciplinary
teams of
evaluators are
needed to
implement the
multiple research
methods needed
for large-scale
evaluations.
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and focus than the evaluation study time frame
and budget allowed; rectifying this imbalance will
require evaluation commissioners to develop
more realistic budgets and timelines, preferably
done in partnership with evaluators.

Triangulation and Synthesis Validates and
Builds Confidence in Evaluation Findings

Triangulation
validates results
from different
sources of data
while synthesis
brings together
findings from
different units of
analysis.

A theory of
change supports
robust
triangulation and
synthesis
processes.

Using multiple methods to address complexity
demands triangulation. There is no other way to
consolidate multiple sources of qualitative and
quantitative information, collected and analyzed
using different methods, and to arrive at useable
evaluation findings and conclusions. In the
evaluation process, when data are unreliable,
scarce, or inconsistent across implementation
settings, methodological triangulation is necessary
to accurately interpret data from different sources
and methods. Workshop participants distinguished between triangulation, which is the analytical process to validate results from different
sources of data or address discordance in findings
related to different sub-questions of an evaluation,
and synthesis, which is the analytical process that
pulls together findings across different units of
analysis to identify context-neutral findings that
can be used in other settings or for scale-up.
All 4 of the large-scale evaluations used
purposive, case-based selection of study units, either
exclusively or as part of their multiple methods
approach. Findings from these nested studies did
not use statistical methods but had to be integrated
with findings from other nested studies that did, in
a robust way to support generalizability of the
overall findings. This could only be done through a
systematic triangulation process and synthesis of
context-specific and context-neutral findings.
In the core workshop examples, triangulation
was done to validate the results and deepen and
broaden the understanding and insights gained
from the evaluation findings. All the triangulation
and synthesis approaches described in the core
examples were grounded in the evaluation’s
purpose and ToC. The PEPFAR evaluation team
conceptualized data triangulation happening at the
levels of analyses and interpretation, instead of data
collection, since data across the entire PEPFAR
program were scarce. They were careful to document what analytical methods were used for what
data, to ensure that the analysis of data from the
multiple methodological sources was as transparent, purposeful, and rigorous as possible. The
PEPFAR evaluation team noted that the quality
and rigor of the causal contribution analysis were
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improved by using triangulation for the different
types of data and different analyses. When
combined with the ToC, this provided a solid basis
to help determine not just whether PEPFAR was
affecting health outcomes but also how and why.
The AMFm team distinguished that triangulating data from multiple sources deepened the
evaluators’ understanding of within-country results,
while synthesizing the findings across countries
contributed to an understanding of how an AMFm
intervention could work in other countries in the
future, by identifying the key factors that contributed to strong performance and those that
were associated with weaker performance.
Evaluations from the Global Environment
Fund (GEF) examined progress from outcomes to
impact, usually in the face of sparse data, in
particular country program objectives and indicators
and national statistics on environmental indicators
and data series over the 20 or so years of a typical
evaluation time frame. To overcome this data
scarcity, GEF uses a standard set of data-gathering
methods and tools that include desk and literature
reviews, portfolio analyses, and in-depth interviews,
in addition to GEF-specific methods, such as
analyses of a country’s environmental legal framework. All these methods are deployed within the
context of an evaluation matrix that the GEF
develops for each evaluation, which then feeds
into a triangulation matrix.1 In the triangulation
process, the evaluation team brainstorms questionby-question to populate the matrix and discuss
which findings are credible and which need further
analysis. After the brainstorming meeting, the team
tries to confirm or challenge the key preliminary
evaluation findings and identify what else can be
done to fill in the missing information, using the
GEF’s theory-based approach to examine progress
from outcomes to impact.
Presenters of the 4 core examples emphasized
the importance of the ToC in supporting robust
triangulation and synthesis processes. For example, in reaching the conclusion that context was
most likely the most important contributing
factor to performance differences across countries, the AMFm evaluation relied on the ToC to
help them parse the findings. The PEPFAR
evaluation was able to determine not only
whether PEPFAR was affecting health outcomes
but also how and why, through a process of
triangulation of multiple sources of data and
multiple analyses, in combination with the ToC.1
The PEPFAR ToC was the key to high-quality,
rigorous causal chain analysis that provided
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a solid evidence base for the evaluation’s conclusions and recommendations.
Workshop participants expressed that evaluators
need better guidance on triangulation and synthesis
and that implementers and commissioners need to
understand what is involved with these analytical
processes, because they take time, yet are crucial for
producing the evaluation results that are expected.
Systematic triangulation and synthesis across
study units is important for increasing confidence
in the reliability, credibility, and applicability of
evaluation findings, especially when case-based,
non-probability–based evaluation designs are used.
However, participants agreed that evaluators should
continually assess the purpose of the triangulation
or synthesis exercise: Is it enriching survey data
with qualitative findings? Assessing hypotheses
emerging from analysis of one data source with
results from another? Explaining unexpected results
using another source of data? Verifying or rejecting
conclusions based on the concordance or discordance of results from different sources of data? Each
requires a different process of triangulation and
synthesis, and each requires sufficient time and
input from the multidisciplinary team that must be
adequately budgeted and planned by evaluators and
evaluation commissioners.

WHY ARE THE KEY MESSAGES FROM THE
IOM WORKSHOP IMPORTANT?
Each of the 3 areas identified at the IOM
workshop presents an important opportunity for
evaluators, commissioners, and implementers to
do better with evaluating large-scale and complex
global health initiatives. Addressing the 3 critical
areas identified here will become increasingly
important in the future: our evaluation questions,
the settings in which we implement, and the
initiatives themselves, are becoming more complex and interlinked. Evaluators, program implementers, and commissioners of evaluations must
address the issues identified through the IOM
workshop, and soon. We need evaluations of
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large-scale global health initiatives that speak to
both their complexity and the specificity of
implementation context in order for the findings
to be useful. We need to improve how we
commission, conduct, consume, and convert
evaluation findings from complex global health
initiatives to improvements in implementation
and impact. Without sufficient and immediate
attention to these 3 areas from all parties, we risk
continued low returns on our evaluation investments and minimal progress in building the
evidence base for improved global health.
Acknowledgments: The workshop was sponsored by the Doris Duke
Charitable Foundation, the Bill and Melinda Gates Foundation, the
William and Flora Hewlett Foundation, and the Wellcome Trust. The
Wellcome Trust hosted the workshop. Individual presentations and
videos from the IOM workshop can be found on the IOM website at:
http://iom.edu/Activities/Global/EvaluationMethodsGlobalHealth/
2014-JAN-07.aspx. The authors would like to thank the IOM for
conducting the workshop, and Bridget Kelly of the IOM for her input and
guidance on this commentary. The authors did not receive financial
support from IOM or any other sources to produce this commentary.

Systematic
triangulation and
synthesis is
important for
increasing
confidence in the
reliability,
credibility, and
applicability of
evaluation
findings.

Competing Interests: None declared.

REFERENCES
1. Institute of Medicine of the National Academies. Evaluation
design for complex global initiatives: workshop summary.
Washington (DC): National Academies Press; 2014. Available
from: http://www.nap.edu/catalog.php?record_id = 18739
2. Institute of Medicine. Evaluation of PEPFAR. Washington (DC):
National Academies Press; 2013. Available from: http://books.
nap.edu/openbook.php?record_id = 18256
3. Sherry J, Mookherji S, Ryan L. The five-year evaluation of the Global
Fund to Fight AIDS, Tuberculosis and Malaria: synthesis of study
areas 1, 2 and 3. [Fairfax (VA)]: Macro International; 2009.
Available from: http://www.theglobalfund.org/documents/terg/
TERG_FiveYearEvaluationSynthesisOfSAs_Report_en/
4. Simon J, Yeboah-Antwi K, Schapira A, Cham MK, BarberMadden R, Brooks MI. External evaluation of the Presidents
Malaria Initiative: final report. Washington (DC): Global Health
Technical Assistance Project; 2011. Available from: http://www.
pmi.gov/docs/default-source/default-document-library/pmireports/audit_execsum.pdf?sfvrsn = 9
5. Tougher S; ACTwatch Group, Ye Y, Amuasi JH, Kourgueni IA,
Thomson T, et al. Effect of the Affordable Medicines Facility—
malaria (AMFm) on the availability, price, and market share of
quality-assured artemisinin-based combination therapies in seven
countries: a before-and-after analysis of outlet survey data.
Lancet. 2012;380(9857): 1916–1926. CrossRef. Medline

Peer Reviewed
Received: 2014 Oct 23; Accepted: 2015 Apr 14; First Published Online: 2015 May 20
Cite this article as: Mookherji S, Meck K. How can we better evaluate complex global health initiatives? reflections from the january 2014
institute of medicine workshop. Glob Health Sci Pract. 2015;3(2):174-179. http://dx.doi.org/10.9745/GHSP-D-14-00184.
& Mookherji et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly cited. To view a copy of the
license, visit http://creativecommons.org/licenses/by/3.0/. When linking to this article, please use the following permanent link: http://dx.doi.
org/10.9745/GHSP-D-14-00184.

Global Health: Science and Practice 2015 | Volume 3 | Number 2

179

